Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

24.73 -0.59 (-2.33%)

Streaming Delayed Price Updated: 2:19 PM EDT, Apr 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agios Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

7 Biotech Stocks Fighting America’s Deadliest Diseases ↗

February 08, 2024

Although the human condition can be alarmingly frail at times, these groundbreaking biotech stocks are aiming to right the ship.

Via InvestorPlace

Why Is Blood Disorder Focused Agios Pharmaceuticals Stock Trading Higher Today? ↗

January 03, 2024

Agios Pharmaceuticals Inc (NASDAQ: AGIO) says the Phase 3 ENERGIZE study of mitapivat in adults with non-transfusion-dependent (NTD) alpha- or beta-thalassemia achieved its primary

Via Benzinga

Agios Pharma Surges, And Retakes Its 200-Day Line, On Promising Test Results For Thalassemia Drug ↗

January 03, 2024

The company is working on an oral treatment for alpha and beta thalassemia.

Via Investor's Business Daily

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 03, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 03, 2024

It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning!

Via InvestorPlace

RBC Capital Maintains Outperform Rating for Agios Pharmaceuticals: Here's What You Need To Know ↗

June 27, 2023

Via Benzinga

Agios Pharmaceuticals's Return On Capital Employed Overview ↗

May 15, 2023

Via Benzinga

Agios Touts Encouraging Action From Sickle Cell Disease Study With Mitapivat ↗

June 26, 2023

Agios Pharmaceuticals Inc (NASDAQ: AGIO) announced that the Phase 2 portion of the global Phase 2/3 RISE UP study of mitapivat in sickle cell disease met its

Via Benzinga

Why Shares of Schrödinger Rose This Week ↗

June 16, 2023

Interest in the company's AI platform continues to drive the stock.

Via The Motley Fool

7 Biotech Stocks to Buy for 100% Returns ↗

April 09, 2023

If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.

Via InvestorPlace

7 Biotech Stocks That Could Be the Next Big Thing ↗

March 15, 2023

Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.

Via InvestorPlace

Agios Pharmaceuticals's Return On Capital Employed Insights ↗

February 24, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗

February 03, 2023

Via Benzinga

3 Under-the-Radar Biotech Stocks to Buy in 2022 ↗

December 24, 2022

The attraction of all three biotech stocks is their potential.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗

November 17, 2022

Upgrades

Via Benzinga

Agios Pharmaceuticals's Return On Capital Employed Overview ↗

November 17, 2022

Via Benzinga

Looking Into Agios Pharmaceuticals Return On Capital Employed ↗

August 15, 2022

Via Benzinga

Europe Approves Agios Pharma's Mitapivat For Adult Pyruvate Kinase Deficiency Patients ↗

November 11, 2022

Via Benzinga

Agios Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2022

Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Agios Pharmaceuticals Stock Clears Key Benchmark, Hitting 90-Plus RS Rating ↗

September 02, 2022

Agios Pharmaceuticals stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 65 to 93.

Via Investor's Business Daily

Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday ↗

September 01, 2022

Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) jumped 48.5% to $19.90 after Novo Nordisk announced it will acquire the company for $20 per share in cash.

Via Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Gainers

Via Benzinga

Agios Pharmaceuticals: Q2 Earnings Insights ↗

August 04, 2022

Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session ↗

September 01, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022 ↗

July 27, 2022

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. Stock Futures Higher; All Eyes On Inflation Data ↗

July 13, 2022

Pre-open movers

Via Benzinga

Delta Air Lines, Fastenal And 3 Stocks To Watch Heading Into Wednesday ↗

July 13, 2022

With the US stock futures trading slightly higher this morning on Wednesday after recording losses in the previous session, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.